SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-098727
Filing Date
2010-11-01
Accepted
2010-11-01 15:12:26
Documents
7
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c07238e10vq.htm 10-Q 463353
2 EX-10.1 AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT c07238exv10w1.htm EX-10.1 19284
3 EX-10.2 SUBSIDIARIES OF THE COMPANY c07238exv10w2.htm EX-10.2 2891
4 EX-31.1 SECTION 302 CERTIFICATION OF CEO c07238exv31w1.htm EX-31.1 5865
5 EX-31.2 SECTION 302 CERTIFICATION OF CFO c07238exv31w2.htm EX-31.2 5854
6 EX-32.1 SECTION 906 CERTIFICATION OF CEO c07238exv32w1.htm EX-32.1 3468
7 EX-32.2 SECTION 906 CERTIFICATION OF CFO c07238exv32w2.htm EX-32.2 3465
  Complete submission text file 0000950123-10-098727.txt   505617
Mailing Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 60 HAMPSHIRE STREET CAMBRIDGE MA 02139 617-995-9800
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605
Type: 10-Q | Act: 34 | File No.: 000-49839 | Film No.: 101154695
SIC: 2834 Pharmaceutical Preparations